Old Web
English
Sign In
Acemap
>
authorDetail
>
Tatsuya Yoshihara
Tatsuya Yoshihara
Memorial Hospital of South Bend
Pharmacology
Diabetes mellitus
Tolerability
Cerebrospinal fluid
Pharmacokinetics
2
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
2017
The Journal of Clinical Pharmacology
Kei Sakamoto
Shunji Matsuki
Kyoko Matsuguma
Tatsuya Yoshihara
Naoki Uchida
Fumihiko Azuma
Muir Russell
Glen Hughes
Samantha Budd Haeberlein
Robert Alexander
Susanna Eketjäll
Alan R. Kugler
Show All
Source
Cite
Save
Citations (28)
ASSESSMENT OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECTS ON PLASMA AND CEREBROSPINAL FLUID AB PEPTIDES OF AZD3293, A NOVEL BACE1 INHIBITOR, IN HEALTHY JAPANESE ADULTS
2016
Alzheimers & Dementia
Tatsuya Yoshihara
Kei Sakamoto
Shunji Matsuki
Kyoko Matsuguma
Naoki Uchida
Fumihiko Azuma
Muir Russell
Glen Hughes
Samantha Budd Haeberlein
Robert C. Alexander
Alan R. Kugler
Show All
Source
Cite
Save
Citations (0)
1